Waverley Pharma Inc.
WAVE.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.10K | -46.60K | -200.10K | -252.00K | -195.90K |
| Total Depreciation and Amortization | 14.90K | 14.90K | 2.40K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.60K | 42.40K | 21.30K | 21.90K | 23.20K |
| Change in Net Operating Assets | -105.90K | -78.20K | 210.70K | 47.20K | 89.60K |
| Cash from Operations | -112.60K | -67.50K | 34.30K | -182.90K | -83.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 184.30K | -- | -- | -- | -- |
| Cash Acquisitions | -152.70K | 100.00 | -448.50K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 31.60K | 100.00 | -448.50K | -- | -- |
| Total Debt Issued | 32.50K | 94.60K | 749.10K | 251.40K | 113.20K |
| Total Debt Repaid | -8.60K | -9.90K | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.60K | 60.50K | 549.20K | 183.70K | 84.00K |
| Foreign Exchange rate Adjustments | -- | 4.40K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -64.30K | -2.40K | 135.00K | 800.00 | 800.00 |